Skip to main content
Download PDF

The effectiveness of supplemental oxygen during exercise training in patients with chronic obstructive pulmonary disease who show severe exercise-induced desaturation: a protocol for a meta-regression analysis and systematic review

Systematic Reviews volume 10, Article number: 110 (2021) Cite this article

Abstract

Background

Supplemental oxygen during exercise training is used to increase the training effect of an exercise program in patients with chronic obstructive pulmonary disease (COPD) who show exercise-induced desaturation. Exercise-induced desaturation is not clearly defined in the guidelines; however, it is generally defined in clinical studies as a decrease in SpO2 of more than 4% from rest or a decrease to less than 88% during exercise. Although some meta-analyses examined the effectiveness of supplemental oxygen during exercise training, these studies concluded that it does not further improve exercise tolerance compared to exercise training alone. However, supplemental oxygen during exercise training may be effective in improving exercise tolerance in COPD patients with severe exercise-induced desaturation. Therefore, this study will be performed to elucidate the effectiveness of supplemental oxygen during exercise training and the relationship between its effectiveness and severity of exercise-induced desaturation at baseline.

Methods

We will first assess the effectiveness of supplemental oxygen during exercise training in COPD. The main outcome is the change in exercise tolerance before and after the intervention, indicated by the 6-min walking distance, the walking distance, or the walking time in incremental shuttle walking test, and analyzed as the standardized mean difference (SMD). The quality and risk of bias in individual studies will be assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system and risk-of-bias tool (RoB ver.2). If statistical heterogeneity in terms of the effectiveness of exercise tolerance is shown, we will conduct meta-regression analyses to examine the association between the effectiveness of exercise training with supplemental oxygen and severity of exercise-induced desaturation at baseline.

Discussion

One strength of this study is that it is a systematic review with meta-regression analysis to elucidate the effectiveness of supplemental oxygen during exercise training in patients with COPD who show severe exercise-induced desaturation. Furthermore, we will assess the severity of exercise-induced desaturation for which exercise training with supplemental oxygen is effective, the influence of acute effects at baseline, and the effect of supplemental oxygen on adverse events.

Systematic review registration

Registration number, UMIN000039960.

Peer Review reports

Description of the condition

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by persistent respiratory symptoms and airflow limitation due to airway and alveolar abnormalities caused by exposure to harmful particles or gasses [1]. An epidemiological study estimated that COPD has an incidence of 384 million in 2020, with a prevalence of 11.7% worldwide [2]. Globally, 3 million people die from COPD annually [3].

As it has been reported that exercise training in rehabilitation improves exercise tolerance, which is related to mortality in COPD [4], the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria recommend rehabilitation regardless of the severity of COPD [1]. However, as COPD patients who show exercise-induced desaturation are not able to tolerate high-intensity training, its effectiveness in such cases is limited. In COPD, exercise-induced desaturation is caused by decreases in diffusion capacity and ventilation-perfusion mismatch due to alveolar destruction and airflow obstruction, respectively [5, 6]. Exercise-induced desaturation is not clearly defined in the guidelines; however, it is generally defined in clinical studies as a decrease in SpO2 of more than 4% from rest or a decrease to less than 88% during exercise. The patients with severe COPD have more severe exercise-induced desaturation as a result of worsening alveolar hypoventilation by dynamic lung hyperinflation related to airflow limitation on exertion [7, 8]. As exercise-induced desaturation is involved in adverse sequelae and higher risk of mortality in COPD [9, 10], supplemental oxygen during exercise training has been prescribed in COPD patients who show severe desaturation.

The effectiveness of combined supplemental oxygen and exercise training remains unclear. Previous studies showed a twofold increase in exercise training load in the supplemental oxygen group compared to the control group, and therefore, the supplemental oxygen group also showed improvements in exercise tolerance, dyspnea, and depressive symptoms [11, 12]. However, other studies failed to show significant improvements in exercise tolerance with supplemental oxygen [13, 14]. In 2007 and 2019, meta-analyses were conducted to elucidate the effectiveness of supplemental oxygen during exercise training [15, 16]. The meta-analysis in 2019 concluded that supplemental oxygen during exercise training does not further improve exercise tolerance compared to exercise training alone [16]. However, especially in COPD patients with severe exercise-induced desaturation, supplemental oxygen during exercise training may be effective in improving exercise tolerance. In moderate to severe COPD patients with SpO2 during exercise ≥ 90%, endurance training three times/week resulted in significant improvements in quality of life (QOL) and exercise capacity independent of oxygen supplementation; however, there were no further benefits of supplemental oxygen from 12 to 24 weeks despite progressively increased training loads [17]. Therefore, we will conduct meta-regression analyses to examine the association between the effectiveness of exercise training with supplemental oxygen and the severity of exercise-induced desaturation. A previous study reported that patients with exercise-induced desaturation and who improved exercise tolerance of 10% or more by ambulatory oxygen on endurance shuttle walk test at baseline showed significant improvements in exercise tolerance by a 6–7-week exercise training program with supplemental oxygen [18]. Therefore, we will also conduct meta-regression analyses to examine the association between the effectiveness of exercise training with supplemental oxygen and acute effects of supplemental oxygen at baseline as a subgroup analysis.

Objectives

The objective of this systematic review and meta-regression analysis is to elucidate the effectiveness of supplemental oxygen during exercise training and the relationship between its effectiveness and severity of desaturation in COPD.

Methods and analyses

This systematic review will be conducted according to the Cochrane Handbook for Systematic Review of Interventions, the Preferred Reporting Items for Systematic Reviews, and reported according to the standards of Meta-Analyses (PRISMA) statement [19, 20]. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system will be used to assess the evidence in cumulative evidence [21]. This protocol paper was prepared according to PRISMA-P [22].

Type of study

Randomized controlled trials (RCTs) regardless of cluster or individual randomization until March 31, 2021, will be included restricted to those published in English. Also, full-text studies, those published as abstracts only, and unpublished data are eligible for inclusion. We will only include RCTs with supplemental oxygen during exercise training for COPD and exclude RCTs related to ambulatory oxygen or long-term oxygen therapy.

Type of participants

We will include participants 18 years of age or older, with a diagnosis of COPD diagnosed according to the GOLD criteria [1]. We will exclude participants with other respiratory diseases including asthma and COPD overlap and combined pulmonary fibrosis and emphysema.

Type of intervention and comparators

The active treatment group will receive supplemental oxygen during exercise training using wall oxygen units in a hospital or clinic, portable oxygen cylinders, liquid oxygen canisters, and oxygen concentrators.

The control group will be provided sham gas, such as compressed air, through a wall unit or cylinders or will receive no intervention under room air.

The exercise training performed in both groups is defined as a supervised or unsupervised inpatient, outpatient, home-based intervention that includes some form of exercise training applied to COPD patients.

Types of outcome

Primary outcome

  1. 1.

    Exercise capacity, e.g., 6-min walking distance (6MWD: m), shuttle walking distance (SWD: m), the walking time in incremental shuttle walking test (SWT: min), peak oxygen consumption. (Peak VO2: mL/kg/min).

  2. 2.

    Maximum exercise load of exercise training, e.g., workload (Watts).

  3. 3.

    Dyspnea scores at the end of the exercise test, e.g., Borg score.

  4. 4.

    Health-related QOL assessed by questionnaires, e.g., 36-Item Short Form Health Survey (SF-36).

  5. 5.

    Number of adverse events, e.g., adverse events assessed by Common Terminology Criteria for Adverse Events (CTCAE)

Search methods for identification of studies

Electronic searches

The meta-analysis should be conducted according to the Cochrane handbook guidance and reported according to PRISMA Statement [19, 20]. We will conduct searches for studies with inception dates up to March 31, 2021, in the Cochrane Central Register of Controlled Trials (CEN-TRAL), MEDLINE, and EMBASE electronic databases. We will also search abstracts and meeting presentations utilizing the same search terms from Medical Subject Headings (MeSH). The search strategy will be based on discussions with an information specialist and will be modified appropriately for each database. The search strategy includes a combination of free text words, words in titles/abstracts, and medical subject headings, such as “pulmonary disease, chronic obstructive,” “supplemental oxygen,” “oxygen inhalation therapy,” and “exercise.” Searches are limited to peer-reviewed research involving human participants. The detailed strategy and details of the formula that will be used to search the databases are shown in Table 1.

Table 1 The detailed strategy and details of formula for search in databases
Full size table

Searching other resources

We will check the reference lists of all primary studies and review articles for additional references. Further, we will contact experts in the field to ask if they know of any ongoing or unpublished trials.

Selection of studies

Two review authors (SK and SY) will independently screen the titles and abstracts of all potentially relevant studies identified by the search and code them as “retrieve” (eligible or potentially eligible/unclear) or “do not retrieve.” In the case of disagreements, other review authors will be asked to arbitrate (KN and TY). SK and SY will retrieve the full text reports/publications and independently screen the full texts and identified studies for inclusion. SK and SY will also identify and record reasons for the exclusion of ineligible studies. Any disagreements will be resolved by discussion or by consulting other review authors (KN and TY) when necessary. The review authors will identify and exclude duplicates and collate multiple reports of the same study so that the unit of interest in the review will be each study, rather than each report. We will record the selection process in sufficient detail to complete a PRISMA flow diagram and “Characteristics of excluded studies” table. A data collection form piloted in at least one study in the review will be used to record study characteristics and outcome data. Two review authors (SK and SY) will extract characteristics from the included studies as follows:

  1. 1.

    Methods: study design, total duration of study, duration of follow-up, number of subjects, study setting, and date of study.

  2. 2.

    Participants: sample size, mean age, sex, history of smoking, history of oxygen therapy, forced expiratory volume in 1 s (FEV1) after bronchodilator administration, and arterial partial pressure of oxygen (PaO2) at baseline.

  3. 3.

    Interventions: type of supplemental oxygen device, oxygen supplemental settings, such as continuous flow or demand delivery systems, and their flow rates, type of intervention as control, such as compressed air (and the flow rate), or room air, type of exercise training as frequency, duration, and contents.

  4. 4.

    Outcomes: exercise capacity, maximum exercise load of exercise training, dyspnea scores at the end of exercise test, health-related QOL assessed by questionnaire survey, number of adverse events assessed by Common Terminology Criteria for Adverse Events (CTCAE).

  5. 5.

    Notes: funding for trial and conflicts of interest of the trial authors.

Data collection of studies

Two review authors (SK and SY) will independently extract outcome data from the included studies and check each other’s data extraction. One review author (SK) will transfer data into the Review Manager 5.3 file (RevMan 2019) and the EZR statistical program [23]. SK and SY will double-check that data have been entered correctly by comparing the data presented in the systematic review with the study reports. A second review author (KN) will spot-check the study characteristics for accuracy against the trial report.

Assessment of risk of bias

Two review authors (SK and SY) will independently assess risk of bias for each study using the criteria outlined in the (RoB version 2) in the Cochrane Handbook for Systematic Reviews of Interventions [19]. Any disagreements will be resolved by discussion, by involving other review authors (KN and YT) or by contacting the authors of the included studies. We will assess risk of bias according to the following domains:

  1. 1.

    Bias arising from the randomization process

  2. 2.

    Bias due to deviations from intended interventions

  3. 3.

    Bias due to missing outcome data

  4. 4.

    Bias in measurement of the outcome

  5. 5.

    Bias in selection of the reported result

We will grade each potential source of bias as low risk, some concerns, or high risk and provide a quote from the study report together with a justification for our judgment in the “Risk of bias” table. We will summarize the risk of bias judgments across different studies for each of the domains listed.

Measures of treatment effect

We will analyze continuous data as the mean difference (MD) or standardized mean difference (SMD) with 95% confidence interval (95% CI). The MD is the absolute difference between the mean change before and after the intervention in a trial. The SMD is used as a summary statistic in the meta-analysis when the studies all assessed the same outcome but measured it in a variety of ways. We will enter data presented as a value with a consistent direction of effect. When the standard deviation (SD) for change from the baseline is not available, we will calculate the SD using Review Manager (RevMan) version 5.3. All CIs have two-sided probability coverage of 95%. A p value < 0.05 will be considered significant. We will carry out sensitivity analysis when there is a high risk of bias that could affect the results.

Assessment of heterogeneity

We will assess statistical heterogeneity in each meta-analysis with Tau2, I2, and χ2 statistics following the Cochrane Handbook for Systematic Reviews. We regard heterogeneity as substantial with I2 > 0% and either the Tau2 is > zero or p < 0.10 in the χ2 test for heterogeneity. Data from each study will be pooled with fixed-effects modeling when there is no heterogeneity (p > 0.1, I2 ≤ 40%). We will perform meta-analyses with random-effects models when there is heterogeneity (p < 0.1, I2 > 40%).

Subgroup analysis

We plan to carry out the following subgroup analyses for primary outcomes if we obtain an I2 score > 50%.

  1. 1.

    Severity of hypoxemia of rest at baseline (PaO2 ≤ 60 Torr or PaO2 > 60 Torr)

  2. 2.

    Severity of exercise-induced desaturation at baseline (exercise induced desaturation: either decrease of SpO2 ≥ 4% and nadir SpO2 during exercise ≤ 88% or not-exercise induced desaturation)

  3. 3.

    Severity of airflow limitation (%FEV1 ≥ 50% or %FEV1 < 50%)

  4. 4.

    Type of outcome (6MWD, SWD, Peak VO2, SF-36)

  5. 5.

    Presence or absence of acute effects of supplemental oxygen at baseline (the subjects who improved their exercise tolerance by 10% or more with supplemental oxygen in the exercise load test at baseline or not)

  6. 6.

    Type of exercise training (interval training or not)

We plan to explore differences in outcomes in these subgroups if the number of collected studies is sufficient.

Sensitivity analysis

We plan to carry out sensitivity analysis for primary outcomes if the high risk of bias of some of the included studies affected the results. We will define “high risk” in each study as at least one domain evaluated as “high risk” or some domains are allocated as “some concern” that can decrease the reliability of the results [19]. We plan to carry out the following sensitivity analyses.

Meta-regression

If there is any statistically heterogeneity or methodological heterogeneity, we will perform meta-regression using PaO2 at baseline (Torr) and decreases of SpO2 in exercise tests as covariates to investigate whether the severity of desaturation at baseline affects the effectiveness of exercise tolerance.

Assessment of reporting biases

When 10 or more studies are included in a meta-analysis, we will create a funnel plot and examine its asymmetry visually to explore any publication bias.

Assessment of evidence in individual study

We will use the GRADE criteria to assess the quality of evidence for each outcome according to four levels (high, moderate, low, or very low) [21]. The quality of evidence will be reduced by any one of the following limitations: risk of bias, inconsistency, indirectness, imprecision, and publication bias. Two investigators (SK, SY) will independently conduct those assessments. Investigators will resolve disagreements between the two investigators through discussion, with a third reviewer available for adjudication (KN).

Discussion

The meta-analysis in 2019 concluded that supplemental oxygen during exercise training does not further improve exercise tolerance compared to exercise training alone [16]. However, especially in COPD patients with severe exercise-induced desaturation, supplemental oxygen during exercise training may be effective in improving exercise tolerance. Exercise-induced desaturation is generally defined in clinical studies as a decrease in SpO2 of more than 4% from rest or a decrease to less than 88% during exercise [24]; however, it is not clearly defined in the guidelines. Also, it has not been reported for which severity of exercise-induced desaturation supplemental oxygen during exercise training is most effective. Based on the acute physiological response to supplemental oxygen during exercise in patients with moderate to severe COPD [25, 26], it is expected to effective at least COPD patients who have moderate to severe exercise-induced desaturation. Therefore, we will conduct meta-regression analyses to examine the association between the effectiveness of exercise training with supplemental oxygen and the severity of exercise-induced desaturation.

We will conduct several subgroup analyses in this meta-analysis to assess the heterogeneity of the effects of supplemental oxygen during exercise training. In previous studies, as supplemental oxygen during exercise training was used to achieve higher effects associated with higher exercise loads, the setting of supplemental oxygen was determined, but the targets of SpO2 were not set [12, 14].Therefore, in this meta-analysis, we will confirm whether the exercise training with supplemental oxygen group achieves a higher exercise load. We will also consider the influence of acute effects in supplemental oxygen therapy at baseline. A previous study reported that patients with exercise-induced desaturation and who improved exercise tolerance of 10% or more by ambulatory oxygen on endurance shuttle walk test at baseline showed significant improvements in exercise tolerance by a 6–7-week exercise training program with supplemental oxygen [18]. Therefore, we will conduct a subgroup analysis to examine the association between the effectiveness of exercise training with supplemental oxygen and acute effects of supplemental oxygen at baseline as a subgroup analysis. The quantity and quality of the trials will possibly be the main limitation of this research. In particular, the meta-analysis of the previous study has reported that there was heterogeneity of effects between types of training, such as interval training or not [15]. We will assess statistical heterogeneity between types of training. The adverse events of supplemental oxygen during exercise training will also be assessed as an outcome. Although previous studies have reported the frequent use of supplemental oxygen during exercise training to avoid desaturation [27], it has not been shown to reduce adverse events [14].

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

COPD:

Chronic obstructive pulmonary disease

SMD:

Standardized mean difference

GRADE:

Grading of Recommendations Assessment, Development, and Evaluation

GOLD:

Global initiative for chronic obstructive lung disease

QOL:

Quality of life

PRISMA:

Preferred Reporting Items for Systematic Reviews, Meta-Analyses

RCT:

Randomized controlled trial

6MWD:

6-min walking distance

SWD:

Shuttle walking distance

Peak VO2 :

Peak oxygen consumption

SF-36:

36-Item Short Form Health Survey

CEN-TRAL:

Cochrane Central Register of Controlled Trials

MeSH:

Medical Subject Headings

FEV1 :

Forced expiratory volume in 1 s

PaO2 :

Arterial partial pressure of oxygen

MD:

Mean difference

95% CI:

95% confidence interval

References

  1. Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2019 report), World Health Organization. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2019. Available from:https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf (cited 2019 February 26).

  2. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: systematic review and meta–analysis. J Glob Health. 2015;5(2):020415. https://doi.org/10.7189/jogh.05.020415.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Abubakar II, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.

    Article  Google Scholar 

  4. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.

    Google Scholar 

  5. Wagner PD, Dantzker DR, Dueck R, Clausen JL, West JB. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest. 1977;59(2):203–16. https://doi.org/10.1172/JCI108630.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Elbehairy AF, Ciavaglia CE, Webb KA, Guenette JA, Jensen D, Mourad SM, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. 2015;191(12):1384–94. https://doi.org/10.1164/rccm.201501-0157OC.

    Article  PubMed  Google Scholar 

  7. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med. 2002;166(5):663–8. https://doi.org/10.1164/rccm.2201003.

    Article  PubMed  Google Scholar 

  8. Zafar MA, Tsuang W, Lach L, Eschenbacher W, Panos RJ. Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung. 2013;191(2):177–82. https://doi.org/10.1007/s00408-012-9443-3.

    Article  CAS  PubMed  Google Scholar 

  9. Kent BD, Mitchell PD, McNicholas WT. Hypoxaemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199.

    PubMed  PubMed Central  Google Scholar 

  10. Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaíme A, et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008;134(4):746–52. https://doi.org/10.1378/chest.08-0520.

    Article  PubMed  Google Scholar 

  11. Neunhäuserer D, Steidle-Kloc E, Weiss G, Kaiser B, Niederseer D, Hartl S, Tschentscher M. Egger A, Studnicka M. Supplemental oxygen during high-intensity exercise training in nonhypoxemic chronic obstructive pulmonary disease. Am J Med 2016: 129: 1185-1193, 11, DOI: https://doi.org/10.1016/j.amjmed.2016.06.023.

  12. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax. 2000;55(7):539–43. https://doi.org/10.1136/thorax.55.7.539.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Wadell K, Henriksson-Larsén K, Lundgren R. Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exerciseinduced hypoxaemia. J Rehabil Med. 2001;33(5):200–5. https://doi.org/10.1080/165019701750419581.

    Article  CAS  PubMed  Google Scholar 

  14. Alison JA, McKeough ZJ, Leung RW, Holland AE, Hill K, Morris NR, et al. Oxygen compared to air during exercise training in COPD with exercise-induced desaturation. Eur Respir J. 2019;53(5):1802429. https://doi.org/10.1183/13993003.02429-2018.

    Article  CAS  PubMed  Google Scholar 

  15. Nonoyama M, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007;18:CD005372.

    Google Scholar 

  16. Liu Y, Gong F. Determination of whether supplemental oxygen therapy is beneficial during exercise training in patients with COPD: a systematic review and meta-analysis. Exp Ther Med. 2019;18(5):4081–9. https://doi.org/10.3892/etm.2019.8026.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dyer F, Callaghan J, Cheema K, Bott J. Ambulatory oxygen improves the effectiveness of pulmonary rehabilitation in selected patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2012;9(2):83–91. https://doi.org/10.1177/1479972312438702.

    Article  CAS  PubMed  Google Scholar 

  18. Spielmanns M, Fuchs-Bergsma C, Winkler A, Fox G, Krüger S, Baum K. Effects of oxygen supply during training on subjects with COPD who are normoxemic at rest and during exercise: a blinded randomized controlled trial. Respir Care. 2015;60(4):540–8. https://doi.org/10.4187/respcare.03647.

    Article  PubMed  Google Scholar 

  19. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.

  20. David M, Alessandro L, Jennifer T, Altman Douglas G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.

    Article  Google Scholar 

  21. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Broxek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6. https://doi.org/10.1016/j.jclinepi.2010.07.015.

    Article  PubMed  Google Scholar 

  22. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https://doi.org/10.1186/2046-4053-4-1.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  PubMed  Google Scholar 

  24. Dogra AC, Gupta U, Sarkar M, Padam A. Exercise-induced desaturation in patients with chronic obstructive pulmonary disease on six-minute walk test. Lung India. 2015;32(4):320–5. https://doi.org/10.4103/0970-2113.159550.

    Article  PubMed  PubMed Central  Google Scholar 

  25. O’Donnell DE, D’Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(4):892–8. https://doi.org/10.1164/ajrccm.163.4.2007026.

    Article  PubMed  Google Scholar 

  26. Ekstrom M, Ahmadi Z, Bornefalk-Hermansson A, et al. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Database Syst Rev. 2016;11:CD006429.

    PubMed  Google Scholar 

  27. Leung RWM, Alison JA, Jenkins SC, Holland AE, Hill K, Morris NR, et al. Use of supplemental oxygen during exercise testing and training for people with chronic obstructive pulmonary disease: a survey of Australian pulmonary rehabilitation programs. Braz J Phys Ther. 2021;25(1):97–102. https://doi.org/10.1016/j.bjpt.2020.04.003.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research received no specific grants from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Biomedical Laboratory Science, Graduate School of Medicine, Shinshu University, Matsumoto, Japan

    Shohei Kawachi

  2. Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan

    Shohei Kawachi

  3. Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan

    Shuhei Yamamoto

  4. The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan

    Kenichi Nishie

  5. The Department of Respiratory Medicine, Iida Municipal Hospital, Iida, Japan

    Kenichi Nishie

  6. Department of Occupational Therapy, Health Science University, Minamitsuru-gun, Japan

    Takayoshi Yamaga

  7. Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan

    Manaka Shibuya

  8. Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan

    Yasunari Sakai

  9. Department of Clinical Laboratory Sciences, Shinshu University School of Health Sciences, 3-1-1, Asahi, Matsumoto, 390-8621, Japan

    Keisaku Fujimoto

Authors
  1. Shohei Kawachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuhei Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenichi Nishie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takayoshi Yamaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manaka Shibuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasunari Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keisaku Fujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SK and SY contributed to the conception of the study. KN, TY, SM, and YS designed the methods of the systematic review, and KF will supervise those design and analysis. All authors were involved in the critical revision, for the intellectual content, and read and approved the final manuscript.

Corresponding author

Correspondence to Keisaku Fujimoto.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawachi, S., Yamamoto, S., Nishie, K. et al. The effectiveness of supplemental oxygen during exercise training in patients with chronic obstructive pulmonary disease who show severe exercise-induced desaturation: a protocol for a meta-regression analysis and systematic review. Syst Rev 10, 110 (2021). https://doi.org/10.1186/s13643-021-01667-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13643-021-01667-9

Keywords

Systematic Reviews

ISSN: 2046-4053